2018
Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements
Wilson D, Moosa MS, Cohen T, Cudahy P, Aldous C, Maartens G. Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements. Open Forum Infectious Diseases 2018, 5: ofy253. PMID: 30474046, PMCID: PMC6240901, DOI: 10.1093/ofid/ofy253.Peer-Reviewed Original ResearchC-reactive proteinTuberculosis groupAntituberculosis therapyWeek 2Serial C-reactive protein measurementsC-reactive protein measurementTuberculosis treatment responseNegative sputum smearsSmear-negative patientsSmear-negative tuberculosisSymptoms of tuberculosisMedian weight gainCohort of adultsNegative predictive valueAntituberculosis treatmentCRP reductionHIV testingHIV prevalenceAdverse outcomesSputum smearHemoglobin increaseSerial changesWeek 8Treatment responseBaseline values
2012
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, Bamber S, Gengiah S, El-Sadr WM, Friedland G, Abdool Karim S. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Annals Of Internal Medicine 2012, 157: 313-24. PMID: 22944873, PMCID: PMC3534856, DOI: 10.7326/0003-4819-157-5-201209040-00004.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAnti-Retroviral AgentsAntibiotics, AntitubercularCD4 Lymphocyte CountFemaleHIV InfectionsHumansImmune Reconstitution Inflammatory SyndromeImmunocompromised HostIncidenceKaplan-Meier EstimateMaleProspective StudiesRifampinRisk FactorsSeverity of Illness IndexTuberculosisConceptsImmune reconstitution inflammatory syndromeSequential treatment groupIncidence of IRISReconstitution inflammatory syndromeAntiretroviral therapy initiationART initiationTreatment groupsIRIS incidenceSAPiT trialInflammatory syndromeTherapy initiationTreatment initiationTuberculosis treatmentOpen-label clinical trialCells/LCo-infected patientsEarly ART initiationInitiation of ARTTuberculosis treatment initiationSmear-negative tuberculosisHigher hospitalization ratesWeeks of completionBaseline CD4Antituberculosis treatmentNonambulatory patients
2011
Performance Of Bronchoalveolar Lavage Enzyme-Linked Immunospot For Diagnosis Of Smear-Negative Tuberculosis In Hiv-Infected Patients
Cattamanchi A, Ssewanyana I, Magala R, Miller C, Boon S, Davis J, Worodria W, Huang L, Cao H. Performance Of Bronchoalveolar Lavage Enzyme-Linked Immunospot For Diagnosis Of Smear-Negative Tuberculosis In Hiv-Infected Patients. 2011, a1202-a1202. DOI: 10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1202.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply